UBS AM’s Celgene Corp CELG Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-2,951,717	Closed	-$293M	–	2973
2019 Q3	$293M	Sell	2,951,717 -208,959	-7%	-$19.9M	0.2%	102
2019 Q2	$292M	Buy	3,160,676 +330,342	+12%	+$31.4M	0.21%	91
2019 Q1	$267M	Buy	2,830,334 +250,156	+10%	+$21.9M	0.2%	103
2018 Q4	$165M	Buy	2,580,178 +13,281	+0.5%	+$980K	0.14%	155
2018 Q3	$230M	Sell	2,566,897 -458,881	-15%	-$40.6M	0.17%	124
2018 Q2	$240M	Sell	3,025,778 -113,496	-4%	-$9.42M	0.18%	115
2018 Q1	$280M	Sell	3,139,274 -875,499	-22%	-$84M	0.22%	96
2017 Q4	$419M	Sell	4,014,773 -2,020,097	-33%	-$228M	0.36%	62
2017 Q3	$880M	Buy	6,034,870 +78,868	+1%	+$10.7M	0.8%	16
2017 Q2	$774M	Buy	5,956,002 +849,804	+17%	+$104M	0.75%	16
2017 Q1	$635M	Sell	5,106,198 -204,885	-4%	-$24.5M	0.65%	23
2016 Q4	$615M	Sell	5,311,083 -1,045,306	-16%	-$116M	0.69%	24
2016 Q3	$664M	Buy	6,356,389 +769,808	+14%	+$83.3M	0.72%	19
2016 Q2	$551M	Sell	5,586,581 -26,251	-0.5%	-$2.72M	0.62%	25
2016 Q1	$562M	Sell	5,612,832 -158,573	-3%	-$16.3M	0.65%	22
2015 Q4	$691M	Sell	5,771,405 -583,075	-9%	-$67.5M	0.79%	16
2015 Q3	$687M	Sell	6,354,480 -1,170,300	-16%	-$145M	0.76%	19
2015 Q2	$871M	Sell	7,524,780 -250,680	-3%	-$28.7M	0.83%	14
2015 Q1	$896M	Buy	7,775,460 +439,161	+6%	+$52.5M	0.86%	11
2014 Q4	$821M	Buy	7,336,299 +2,632,566	+56%	+$278M	0.78%	16
2014 Q3	$446M	Buy	4,703,733 +40,562	+0.9%	+$3.66M	0.44%	44
2014 Q2	$400M	Sell	4,663,171 -91,313	-2%	-$6.94M	0.4%	56
2014 Q1	$332M	Buy	4,754,484 +412,166	+9%	+$32.6M	0.35%	62
2013 Q4	$367M	Sell	4,342,318 -179,968	-4%	-$14.2M	0.42%	52
2013 Q3	$348M	Sell	4,522,286 -177,138	-4%	-$12.4M	0.43%	48
2013 Q2	$275M	Buy	+4,699,424	New	+$283M	0.35%	63

Other funds holding CELG